Mylan $23 Million Chairman Shows Looming Teva Culture Clash

Updated on

Mylan NV Executive Chairman Robert Coury made $22.7 million, including $1 million for his personal use of the drugmaker’s two corporate jets, in 2012 and 2013. At Israeli rival Teva, shareholders in 2012 balked at raising the chairman’s salary to $900,000 a year.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.